EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tea seed-derived leucoside attenuates sepsis via inhibition of TLR4-MD2 complex formation

Yan Zhang, Yingxue Liang, Wenjuan Li, Lulu Zang, Xi Chen, Xiaofan Xiong, Siyu Zhang, Yuhao Gu, Shuaijie Zhong, Yingnan Li, Jing Geng, Yanlong Xin

Biochemical Pharmacology · 2026-01 · 243 · 117464

DOI: 10.1016/j.bcp.2025.117464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-01. Verfasst von Yan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710004, China; Department of Tumor and Immunology in …. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Sepsis, Lymphocyte Antigen 96, Seeds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recruitment Program of Global Experts, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis, a life-threatening condition driven by dysregulated inflammation, remains a major clinical challenge due to high mortality rates and limited therapeutic options. This study investigates the anti-inflammatory properties of Leucoside, a natural flavonoid isolated from tea seed extract, and its potential as a therapeutic agent for sepsis. Using a bacterial infection-induced septic mouse model and lipopolysaccharide (LPS)-activated macrophages, we demonstrated that Leucoside significantly improves survival rates, reduces hypothermia, and attenuates organ damage by suppressing systemic inflammation. Mechanistically, network pharmacology and molecular docking identified Toll-like receptor 4 (TLR4) as a primary target of Leucoside. Biochemical and structural analyses revealed that Leucoside competitively binds to conserved positively charged residues in the B patch of TLR4, specifically Lys263 and Arg337, forming a spatial barrier that inhibits the formation of the myeloid differentiation protein 2 (MD2)-TLR4 complex and subsequent nuclear factor kappa-B (NF-κB) signaling. This inhibition was further validated through co-immunoprecipitation assays, which showed a reduced effect on the TLR4-MD2 complex dissociation when Lys263 and Arg337 were mutated. These findings highlight Leucoside as a novel TLR4 inhibitor with significant potential for treating sepsis and other TLR4-mediated inflammatory diseases. By elucidating its mechanism of action, this study provides a foundation for developing targeted therapies to address the unmet clinical needs in sepsis management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4SepsisLymphocyte Antigen 96SeedsTeaAnimalsMiceMice, Inbred C57BLMaleRAW 264.7 CellsHumansMolecular Docking Simulation

Stichwörter der Autor:innen

InflammationLPSMacrophageSepsisTLR4Tea seed-derived leucoside

Substanzen

Toll-Like Receptor 4Lymphocyte Antigen 96Ly96 protein, mouseTlr4 protein, mouseTea

Autor:innen und Institutionen

  • Department of General Surgery, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710004, China; Department of Tumor and Immunology in Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jia…
  • Department of Tumor and Immunology in Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710004, China.
  • Neuroscience Research Center, Institute of Mitochondrial Biology and Medicine, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong Univers…

Förderung

  • Recruitment Program of Global Experts
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Xi'an Jiaotong University
  • Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Zhang, Y., Liang, Y., Li, W., Zang, L., Chen, X., Xiong, X., Zhang, S., Gu, Y., Zhong, S., Li, Y., Geng, J., & Xin, Y. (2026). Tea seed-derived leucoside attenuates sepsis via inhibition of TLR4-MD2 complex formation. Biochemical Pharmacology, 243, 117464. https://doi.org/10.1016/j.bcp.2025.117464

Vancouver

Zhang Y, Liang Y, Li W, Zang L, Chen X, Xiong X, et al. Tea seed-derived leucoside attenuates sepsis via inhibition of TLR4-MD2 complex formation. Biochemical Pharmacology. 2026;243:117464. doi:10.1016/j.bcp.2025.117464

BibTeX
@article{Zhang2026,
  author = {Zhang, Yan and Liang, Yingxue and Li, Wenjuan and Zang, Lulu and Chen, Xi and Xiong, Xiaofan and Zhang, Siyu and Gu, Yuhao and Zhong, Shuaijie and Li, Yingnan and Geng, Jing and Xin, Yanlong},
  title = {Tea seed-derived leucoside attenuates sepsis via inhibition of TLR4-MD2 complex formation},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {243},
  pages = {117464},
  doi = {10.1016/j.bcp.2025.117464}
}
Kostenlos starten →